What could be better than a global pandemic? Not having one. Solutions to end early outbreaks, epidemics and pandemics.
Safe rapid mass produced mucosal vaccines for preventing and ending pandemics while still protecting populations against the transmission of diseases within a few weeks of the determination of the pathogen.

Most vaccines take years to develop and in the case of COVID-19 it took almost one year to develop vaccines. For over 2 decades we have been developing techniques, delivery methods and quicker set up to fight new and infectious diseases.
Our powder based mucosal vaccines have a much better safety profile as they are delivered by inhaling or swallowing by mouth or nose for instant protection and provide the first line of defense.

They can be self administered at home. They are non-injection vaccines and need no refrigeration. Delivery and development of food based prevention is now under way. 
Food based delivery methods for protection against viruses that enter through the mouth so as to then protect the mouth, throat, gut and brain are now under way.

Nasal based protection for nose and lungs with customized throat and nasal inhalers.

This would permits home and self administration reducing a great burden to health care systems.    
The word PAN comes the Greek language and means "all" and has in recent years in the scientific world became associated with influenza vaccines in reference to ONE vaccine that contains multiple or a great number immune properties to provide protection against multiple (20) influenzas strains. This became widely spoken and even developed by some companies  during the COVID-19 pandemic.

New PAN vaccines are also under development and potentially could be available in 2025 for a variety of infectious diseases.


During the COVID-19 pandemic a great inequality of transferral and sharing of technology for vaccines was a key and monumental issue and even has led the nations in 2024 to come to a Pandemic Agreement, which failed.

With sharing of technology not only can a pandemic be avoided, but also disease prevention become more globally controlled.

"Ready to license" mass production facilities and technology are now available to be shared not only for LMIC's but all nations.
Rapid mass production of safe, self administered, easy to use, non refrigerated mucosal vaccines in various forms will soon be available to help address vaccine hesitancy.

Much of disease transferral is a result improper stewardship of not just human diseases but animal diseases as well as was witnessed with SARS-CoV-2. So both markets need to be addressed. This is another way to end vaccine hesitancy by protecting our animal kingdom.

Vaccine hesitancy is due to concerns about vaccine safety issues, misinformation, lack of understanding of new technologies, and other issues, but also clearly the inability to PREVENT PANDEMICS IN THE FIRST PLACE which was seen during the Covid-19 pandemic.